COVID-19 Vaccines in Pancreatic Transplant Recipients: A Single-Center Observative Study

Overview

Journal Transplant Proc

Specialty General Surgery

Date 2022 Apr 19

PMID 35437149

Authors

Marta Matejak-Gorska

Michal Zielonka

Hanna Gorska

Marek Durlik

Affiliations

Soon will be listed here.

Abstract

The SARS-CoV-2 pandemic was a real test of doctors' abilities to adapt and respond to patients' needs. The course of infection varied from influenza-like symptoms to severe infections with multi-organ failure and death. Therefore, the possibility of vaccination against the COVID-19 virus brought great hope. Since 2004, 240 pancreas and pancreas with kidney (simultaneous pancreas and kidney transplantation, pancreas after kidney, pancreas transplants alone) transplants were performed in our center. Currently, 130 transplant patients are under the care of the transplant clinic. All patients were informed about the possibility of vaccination against SARS-CoV-2 with the mRNA vaccine. The aim of the study was to evaluate the development of antibodies to SARS-CoV-2 in patients who had previously undergone transplantation. Fifty-three patients were vaccinated with the full double dose and 37 patients received an additional third dose. The level of antibodies in the IgM and IgG classes was assessed in patients' serum. The level of antibodies was assessed before administration of the vaccine and then after administration of the first and second doses. Most patients had no response to vaccination after 1 dose of the vaccine and 21 patients achieved therapeutic antibody levels after the full dose of vaccination. However, the highest titer of immunoglobulins was found in recipients who received the third dose. The use of vaccinations is safe and can protect the group of patients after pancreas transplantation from serious complications of SARS-CoV-2 infection despite the use of immunosuppressive drugs.

References

Westhoff T, Seibert F, Anft M, Blazquez-Navarro A, Skrzypczyk S, Zgoura P . A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse. Kidney Int. 2021; 100(5):1135-1136. PMC: 8427909. DOI: 10.1016/j.kint.2021.09.001. View

Marjot T, Webb G, Barritt A, Gines P, Lohse A, Moon A . SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021; 6(3):156-158. PMC: 7832019. DOI: 10.1016/S2468-1253(21)00008-X. View

Georgery H, Devresse A, Yombi J, Belkhir L, De Greef J, Darius T . Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients. Transplantation. 2021; 105(12):e283-e284. PMC: 8612846. DOI: 10.1097/TP.0000000000003861. View

Williams W, Ingelfinger J . Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients. N Engl J Med. 2021; 385(13):1233-1234. PMC: 8385552. DOI: 10.1056/NEJMe2112866. View

Boyarsky B, Chiang T, Ou M, Werbel W, Massie A, Segev D . Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021; 105(8):e82-e83. PMC: 8298284. DOI: 10.1097/TP.0000000000003850. View

Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A . Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021; 385(7):661-662. PMC: 8262620. DOI: 10.1056/NEJMc2108861. View

Aslam S, Goldstein D, Vos R, Gelman A, Kittleson M, Wolfe C . COVID-19 vaccination in our transplant recipients: The time is now. J Heart Lung Transplant. 2021; 40(3):169-171. PMC: 7834006. DOI: 10.1016/j.healun.2020.12.009. View

Massa F, Cremoni M, Gerard A, Grabsi H, Rogier L, Blois M . Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients. EBioMedicine. 2021; 73:103679. PMC: 8573385. DOI: 10.1016/j.ebiom.2021.103679. View

Meshram H, Kute V, Shah N, Chauhan S, Navadiya V, Patel A . COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India. Transplantation. 2021; 105(9):e100-e103. PMC: 8384248. DOI: 10.1097/TP.0000000000003835. View

10.

Surowiecka-Pastewka A, Matejak-Gorska M, Fraczek M, Durlik M . Reconstruction of Multiple Renal Arteries During Simultaneous Pancreas and Kidney Transplantation: A Case Report. Transplant Proc. 2018; 50(7):2136-2139. DOI: 10.1016/j.transproceed.2018.02.101. View

11.

Caillard S, Thaunat O . COVID-19 vaccination in kidney transplant recipients. Nat Rev Nephrol. 2021; 17(12):785-787. PMC: 8475856. DOI: 10.1038/s41581-021-00491-7. View

12.

Affeldt P, Koehler F, Brensing K, Adam V, Burian J, Butt L . Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients. Microorganisms. 2022; 10(1). PMC: 8779774. DOI: 10.3390/microorganisms10010004. View

13.

Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L . Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021; 99(6):1487-1489. PMC: 7997264. DOI: 10.1016/j.kint.2021.03.014. View

14.

Surowiecka-Pastewka A, Matejak-Gorska M, Fraczek M, Sklinda K, Walecki J, Durlik M . Endovascular Interventions in Vascular Complications After Simultaneous Pancreas and Kidney Transplantations: A Single-Center Experience. Ann Transplant. 2019; 24:199-207. PMC: 6482861. DOI: 10.12659/AOT.912005. View

15.

Surowiecka A, Fraczek M, Mruk B, Matejak-Gorska M, Walecki J, Durlik M . Normal Pancreas Graft Appearance in Magnetic Resonance Diffusion Tensor Imaging (DTI). Med Sci Monit. 2020; 26:e920262. PMC: 7461655. DOI: 10.12659/MSM.920262. View

16.

Tsapepas D, Ali Husain S, King K, Burgos Y, Cohen D, Mohan S . Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City. Am J Health Syst Pharm. 2021; 78(22):2040-2045. PMC: 8344809. DOI: 10.1093/ajhp/zxab272. View

17.

Cucchiari D, Egri N, Bodro M, Herrera S, Del Risco-Zevallos J, Casals-Urquiza J . Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant. 2021; 21(8):2727-2739. PMC: 8222867. DOI: 10.1111/ajt.16701. View

18.

Surowiecka A, Feng S, Matejak-Gorska M, Durlik M . Influence of Peritoneal or Hemodialysis on Results of Simultaneous Pancreas and Kidney Transplant. Exp Clin Transplant. 2019; 18(1):8-12. DOI: 10.6002/ect.2019.0204. View

19.

Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S . Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020; 92(9):1518-1524. PMC: 7228300. DOI: 10.1002/jmv.25727. View

20.

Kedzierska-Kapuza K, Zielinska D, Matejak-Gorska M, Durlik M . The Course of SARS-CoV-2 in a Patient After a Recent Kidney Transplant: A Literature Review on COVID-19 Therapy. Transplant Proc. 2021; 53(4):1194-1201. PMC: 7959262. DOI: 10.1016/j.transproceed.2021.03.008. View